Department of Cardiology I, Coronary and Peripheral Vascular Disease, Heart Failure, University Hospital Muenster, Muenster, Germany.
Division of Vascular Medicine, Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure Medicine, University Hospital Muenster, Muenster, Germany.
Clin Cardiol. 2019 Jun;42(6):629-636. doi: 10.1002/clc.23186. Epub 2019 May 6.
Peripheral artery disease (PAD) is frequently co-prevalent with coronary artery disease (CAD) and diabetes (DM). The study aims to define the burden of CAD and/ or DM in PAD patients at moderate stages and further to evaluate its impact on therapy and outcome.
Study is based on health insurance claims data of the BARMER reflecting an unselected "real-world" scenario. Retrospective analyses were based on 21 197 patients hospitalized for PAD Rutherford 1-3 between 1 January 2009 to 31 December 2011, including a 4-year follow-up (median 775 days).
In PAD patients, CAD is prevalent in 25.3% (n = 5355), DM in 23.5% (n = 4976), and both CAD and DM in 8.2% (n = 1741). Overall, in-hospital mortality was 0.4%, being increased if CAD was present (CAD alone: OR 1.849; 95%-CI 1.066-3.208; DM alone: OR 1.028; 95%-CI 0.520-2.033; CAD and DM: OR 3.115; 95%-CI 1.720-5.641). Both, CAD and DM increased long-term mortality (CAD alone: HR 1.234; 95%-CI 1.106-1.376; DM alone: HR 1.260; 95%-CI 1.125-1.412; CAD and DM: HR 1.76; 95%-CI 1.552-1.995). DM further increased long-term amputation risk (DM alone: HR 2.238; 95%-CI 1.849-2.710; DM and CAD: HR 2.199; 95%-CI 1.732-2.792), whereas CAD (alone) did not.
In a greater perspective, the data identify also mild to modest stage PAD patients at particular risk for adverse outcomes in presence of CAD and/or DM. CAD and DM both are related with a highly increased risk of long-term mortality even in intermittent claudication, and DM independently increased amputation risk.
外周动脉疾病(PAD)常与冠状动脉疾病(CAD)和糖尿病(DM)同时发生。本研究旨在明确处于中度阶段的 PAD 患者中 CAD 和/或 DM 的负担,并进一步评估其对治疗和预后的影响。
本研究基于 BARMER 的医疗保险索赔数据,反映了未经选择的“真实世界”情况。回顾性分析基于 2009 年 1 月 1 日至 2011 年 12 月 31 日期间因 Rutherford 1-3 级 PAD 住院的 21197 例患者,包括 4 年的随访(中位数 775 天)。
在 PAD 患者中,CAD 的患病率为 25.3%(n=5355),DM 的患病率为 23.5%(n=4976),CAD 和 DM 同时存在的患病率为 8.2%(n=1741)。总体而言,住院死亡率为 0.4%,如果存在 CAD,则死亡率增加(CAD 单独存在:OR 1.849;95%CI 1.066-3.208;DM 单独存在:OR 1.028;95%CI 0.520-2.033;CAD 和 DM 同时存在:OR 3.115;95%CI 1.720-5.641)。CAD 和 DM 均增加了长期死亡率(CAD 单独存在:HR 1.234;95%CI 1.106-1.376;DM 单独存在:HR 1.260;95%CI 1.125-1.412;CAD 和 DM 同时存在:HR 1.76;95%CI 1.552-1.995)。DM 进一步增加了长期截肢风险(DM 单独存在:HR 2.238;95%CI 1.849-2.710;DM 和 CAD 同时存在:HR 2.199;95%CI 1.732-2.792),而 CAD(单独存在)则没有。
从更广泛的角度来看,这些数据还确定了处于轻度至中度阶段的 PAD 患者,他们在存在 CAD 和/或 DM 的情况下存在不良预后的风险。CAD 和 DM 均与长期死亡率的高度增加相关,即使在间歇性跛行中也是如此,而 DM 独立增加了截肢风险。